Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy J Mitchell

Showing results (51-60 of 100) with videos related to

Pageof 10
Sort By:
Antimicrobial Agents and Chemotherapy|July 25, 2003
Reduced release of pneumolysin by Streptococcus pneumoniae in vitro and in vivo after treatment with nonbacteriolytic antibiotics in comparison to ceftriaxoneAnnette Spreer, Holger Kerstan, Tobias Böttcher, et al.
Infection and Immunity|January 18, 2002
Sensitivities of human monocytes and epithelial cells to pneumolysin are differentRobert A Hirst, Hasan Yesilkaya, Edwin Clitheroe, et al.
Neuroimaging Clinics of North America|December 3, 2014
Resting-state blood oxygen level-dependent functional magnetic resonance imaging for presurgical planningMudassar Kamran, Carl D Hacker, Monica G Allen, et al.
Cells|December 24, 2021
Neutrophil-Derived Extracellular Vesicles Activate Platelets after Pneumolysin ExposureEleftheria Letsiou, Luiz Gustavo Teixeira Alves, Matthias Felten, et al.
Scientific Reports|August 2, 2016
NLRP3 protects alveolar barrier integrity by an inflammasome-independent increase of epithelial cell adherenceElena Kostadinova, Catherine Chaput, Birgitt Gutbier, et al.
Vaccine|May 21, 2018
Production and efficacy of a low-cost recombinant pneumococcal protein polysaccharide conjugate vaccineJenny A Herbert, Emily J Kay, Sian E Faustini, et al.
Molecular Immunology|February 10, 2009
Identification of the high affinity binding site in the Streptococcus intermedius toxin intermedilysin for its membrane receptor, the human complement regulator CD59Timothy R Hughes, Kirsty S Ross, Graeme J M Cowan, et al.
British Journal of Pharmacology|September 10, 2017
Magnesium therapy improves outcome in Streptococcus pneumoniae meningitis by altering pneumolysin pore formationSabrina Hupp, Sandra Ribes, Jana Seele, et al.
Stereotactic and Functional Neurosurgery|January 20, 2016
Resting-State Blood Oxygen Level-Dependent Functional MRI: A Paradigm Shift in Preoperative Brain MappingEric C Leuthardt, Monica Allen, Mudassar Kamran, et al.
The Journal of Infection|March 8, 2017
Pneumolysin mediates heterotypic aggregation of neutrophils and platelets in vitroJan G Nel, Chrisna Durandt, Annette J Theron, et al.
Pageof 10

Showing results (51-60 of 100) with videos related to

Sort By:
Pageof 10
Antimicrobial Agents and Chemotherapy|July 25, 2003
Reduced release of pneumolysin by Streptococcus pneumoniae in vitro and in vivo after treatment with nonbacteriolytic antibiotics in comparison to ceftriaxoneAnnette Spreer, Holger Kerstan, Tobias Böttcher, et al.
Infection and Immunity|January 18, 2002
Sensitivities of human monocytes and epithelial cells to pneumolysin are differentRobert A Hirst, Hasan Yesilkaya, Edwin Clitheroe, et al.
Neuroimaging Clinics of North America|December 3, 2014
Resting-state blood oxygen level-dependent functional magnetic resonance imaging for presurgical planningMudassar Kamran, Carl D Hacker, Monica G Allen, et al.
Cells|December 24, 2021
Neutrophil-Derived Extracellular Vesicles Activate Platelets after Pneumolysin ExposureEleftheria Letsiou, Luiz Gustavo Teixeira Alves, Matthias Felten, et al.
Scientific Reports|August 2, 2016
NLRP3 protects alveolar barrier integrity by an inflammasome-independent increase of epithelial cell adherenceElena Kostadinova, Catherine Chaput, Birgitt Gutbier, et al.
Vaccine|May 21, 2018
Production and efficacy of a low-cost recombinant pneumococcal protein polysaccharide conjugate vaccineJenny A Herbert, Emily J Kay, Sian E Faustini, et al.
Molecular Immunology|February 10, 2009
Identification of the high affinity binding site in the Streptococcus intermedius toxin intermedilysin for its membrane receptor, the human complement regulator CD59Timothy R Hughes, Kirsty S Ross, Graeme J M Cowan, et al.
British Journal of Pharmacology|September 10, 2017
Magnesium therapy improves outcome in Streptococcus pneumoniae meningitis by altering pneumolysin pore formationSabrina Hupp, Sandra Ribes, Jana Seele, et al.
Stereotactic and Functional Neurosurgery|January 20, 2016
Resting-State Blood Oxygen Level-Dependent Functional MRI: A Paradigm Shift in Preoperative Brain MappingEric C Leuthardt, Monica Allen, Mudassar Kamran, et al.
The Journal of Infection|March 8, 2017
Pneumolysin mediates heterotypic aggregation of neutrophils and platelets in vitroJan G Nel, Chrisna Durandt, Annette J Theron, et al.
Pageof 10